• Open Access

How we manage AB plasma inventory in the blood center and transfusion service

Authors

  • Mark Yazer,

    1. Department of Pathology, University of Pittsburgh and The Institute for Transfusion Medicine, Pittsburgh, Pennsylvania
    2. American Red Cross, National Headquarters, Biomedical Services, Medical Office, Washington, DC
    3. Blood Systems Incorporated, Scottsdale, Arizona
    4. University of Texas Health Science Center, San Antonio, Texas
    Search for more papers by this author
  • Anne F. Eder,

    1. Department of Pathology, University of Pittsburgh and The Institute for Transfusion Medicine, Pittsburgh, Pennsylvania
    2. American Red Cross, National Headquarters, Biomedical Services, Medical Office, Washington, DC
    3. Blood Systems Incorporated, Scottsdale, Arizona
    4. University of Texas Health Science Center, San Antonio, Texas
    Search for more papers by this author
  • Kevin J. Land

    Corresponding author
    1. Department of Pathology, University of Pittsburgh and The Institute for Transfusion Medicine, Pittsburgh, Pennsylvania
    2. American Red Cross, National Headquarters, Biomedical Services, Medical Office, Washington, DC
    3. University of Texas Health Science Center, San Antonio, Texas
    • Blood Systems Incorporated, Scottsdale, Arizona
    Search for more papers by this author

Address reprint requests to: Kevin J. Land, MD, 6210 E. Oak Street, Scottsdale, Arizona 85257-1101; e-mail: kland@bloodsystems.org.

Abstract

The growing use of group AB plasma in the United States in recent years poses unique challenges to blood centers and transfusion services. Blood centers must collect sufficient plasma components from a limited pool of group AB donors while taking steps to improve transfusion safety that further restricts the available supply. Transfusion services, on the other hand, must use the finite resource in the most conscientious and medically appropriate manner. Recently, many investigations have challenged long-held beliefs about transfusion practice and appropriate indications for blood components across a variety of specialties. Balancing supply and demand of group AB plasma requires collaboration between blood suppliers and transfusion services, and opportunities for improvement exist on both sides of the equation.

Ancillary